US approves first gene therapy for children with rare genetic disease

The approval was based on data from 37 children who received Lenmeldy in two open-label clinical trials, whose results showed that the therapy significantly reduced the risk of severe motor impairment or death compared with untreated children.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/5AnsGB2
via